These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 14529398)

  • 1. Cyclooxygenase-2 biology.
    Clària J
    Curr Pharm Des; 2003; 9(27):2177-90. PubMed ID: 14529398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.
    Khanapure SP; Garvey DS; Janero DR; Letts LG
    Curr Top Med Chem; 2007; 7(3):311-40. PubMed ID: 17305573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-1 and COX-2 in health and disease.
    Adelizzi RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P; van der Bijl P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
    Cronstein BN
    Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies.
    Tapiero H; Ba GN; Couvreur P; Tew KD
    Biomed Pharmacother; 2002 Jul; 56(5):215-22. PubMed ID: 12199620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase enzymes in allergic inflammation and asthma.
    Carey MA; Germolec DR; Langenbach R; Zeldin DC
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):157-62. PubMed ID: 12895598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cyclo-oxygenase-2.
    Stack E; DuBois RN
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cox-2-specific inhibitors: definition of a new therapeutic concept.
    Verburg KM; Maziasz TJ; Weiner E; Loose L; Geis GS; Isakson PC
    Am J Ther; 2001; 8(1):49-64. PubMed ID: 11304658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological analysis of cyclooxygenase-1 in inflammation.
    Smith CJ; Zhang Y; Koboldt CM; Muhammad J; Zweifel BS; Shaffer A; Talley JJ; Masferrer JL; Seibert K; Isakson PC
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13313-8. PubMed ID: 9789085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept.
    Gaddi A; Cicero AF; Pedro EJ
    Arch Gerontol Geriatr; 2004; 38(3):201-12. PubMed ID: 15066307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 inhibition and the control of pain.
    Kiefer W; Dannhardt G
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1348-58. PubMed ID: 12498012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
    Kulkarni SK; Jain NK; Singh A
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):291-8. PubMed ID: 11031730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
    Stańczyk J; Kowalski ML
    Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with cyclooxygenase-2 inhibitors.
    van Ryn J; Pairet M
    Inflamm Res; 1999 May; 48(5):247-54. PubMed ID: 10391112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.